Position in RGNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,717,509
+$3,426,106 QoQ
Shares Held
560,727
+42.8% QoQ
Ownership
0.849%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 163 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $537,727,692 across 104 Biotechnology names. RGNX ranks #12 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
9,941,165 | $147,924,534 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
162,151 | $80,545,262 | |
| 3 | MANE |
Veradermics, Inc
|
294,117 | $36,158,743 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
139,491 | $33,613,146 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
46,378 | $28,918,535 | |
| 6 | OMER |
Omeros Corp
|
1,836,925 | $17,469,155 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
1,014,387 | $17,163,427 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
202,983 | $16,094,521 |
All Filings in RGNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,717,509 | 560,727 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,291,403 | 392,769 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,824,661 | 335,046 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,091,955 | 320,410 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,554,187 | 311,107 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,352,106 | 328,966 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,459,762 | 188,844 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,565,946 | 149,280 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,541,087 | 131,717 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,908,835 | 90,595 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,219,683 | 67,949 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,083,083 | 65,801 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,198,939 | 59,977 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $875,513 | 46,299 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $777,810 | 34,295 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $734,701 | 27,798 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $623,922 | 25,260 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $680,693 | 20,509 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $486,674 | 14,883 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $457,263 | 10,908 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $242,384 | 6,239 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||